Research location

Prague

Prague, Czechia

Published trials32

Site observations47

Linked trials published32

Page1 / 1

Research activity in Prague

Prague, Czechia

CureCurrent currently publishes aggregate city-level research activity for this location: 32 trials and 47 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Prague

32 linked trials · page 1 of 1

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · 2026-06-01 · 1 site observation

Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureNCT07527156 · 2026-04-04 · 1 site observation

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)NCT07276724 · 2025-12-03 · 1 site observation

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation

Conservative vs Interventional Management of Postsurgical CSF PseudomeningoceleNCT07614399 · 2025-11-01 · 1 site observation

Strength-Endurance Circuit Training in Parkinson's DiseaseNCT06893055 · 2025-03-03 · 1 site observation

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesNCT07284901 · 2026-01-12 · 1 site observation

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have DiabetesNCT07284875 · 2025-12-18 · 2 site observations

ACTIVE_NOT_RECRUITING

Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center StudyNCT07032246 · 2025-10-09 · 1 site observation

ENROLLING_BY_INVITATION

A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)NCT06490445 · 2024-11-14 · 1 site observation

A Study of Mosliciguat in PH-ILDNCT06635850 · 2024-10-29 · 2 site observations

ACTIVE_NOT_RECRUITING

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsNCT06553027 · 2024-09-20 · 3 site observations

ACTIVE_NOT_RECRUITING

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNCT06058039 · 2023-12-21 · 1 site observation

Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439 · 2023-11-10 · 1 site observation

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)NCT06193239 · 2023-10-05 · 1 site observation

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesNCT05794906 · 2023-04-03 · 3 site observations

ACTIVE_NOT_RECRUITING

Low-carbohydrate Diet in Children with Type 1 DiabetesNCT05078658 · 2021-09-22 · 1 site observation

ACTIVE_NOT_RECRUITING

Ideal Marker for Targeted Axillary DissectionNCT04580251 · 2021-01-01 · 1 site observation

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)NCT04597125 · 2020-11-09 · 4 site observations

ACTIVE_NOT_RECRUITING

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation

ACTIVE_NOT_RECRUITING

ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid ArthritisNCT03428763 · 2020-08-18 · 1 site observation

MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisNCT04512001 · 2020-08-03 · 1 site observation

Study of LM11A-31-BHS in Mild-moderate AD PatientsNCT03069014 · 2017-02-15 · 1 site observation

Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabNCT02937701 · 2016-10-10 · 2 site observations

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateNCT02889796 · 2016-08-30 · 1 site observation

Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid ArthritisNCT02114931 · 2014-04-01 · 2 site observations

Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019NCT01797965 · 2013-02-15 · 2 site observations

Trazodone Once a Day in Major Depression DisorderNCT02086929 · 2012-12-01 · 4 site observations

A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).NCT01726413 · 2012-11-01 · 1 site observation

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneNCT01555164 · 2012-06-01 · 1 site observation

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple SclerosisNCT01064401 · 2010-05-01 · 1 site observation

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.